157 related articles for article (PubMed ID: 1679336)
1. Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.
Kujacic M; Svensson K; Löfberg L; Carlsson A
J Neural Transm Gen Sect; 1991; 84(3):195-209. PubMed ID: 1679336
[TBL] [Abstract][Full Text] [Related]
2. Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists.
Kujacic M; Svensson K; Löfberg L; Carlsson A
Eur J Pharmacol; 1990 Feb; 177(3):163-70. PubMed ID: 1968848
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors.
Kujacic M; Carlsson A
J Neural Transm Gen Sect; 1993; 92(2-3):73-9. PubMed ID: 8103662
[TBL] [Abstract][Full Text] [Related]
4. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
[TBL] [Abstract][Full Text] [Related]
5. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
Damase-Michel C; Montastruc JL; Gharib C; Geelen G; De Saint-Blanquat G; Tran MA
J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
[TBL] [Abstract][Full Text] [Related]
6. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
Clark D; Salah RS; Galloway MP
Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
[TBL] [Abstract][Full Text] [Related]
7. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
[TBL] [Abstract][Full Text] [Related]
8. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
Wachtel H; Kehr W; Sauer G
Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
[TBL] [Abstract][Full Text] [Related]
9. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
Imperato A; Tanda G; Frau R; Di Chiara G
J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
[TBL] [Abstract][Full Text] [Related]
11. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
[TBL] [Abstract][Full Text] [Related]
12. Effect of apomorphine on adrenal medullary catecholamine levels.
Montastruc JL; Gaillard G; Rascol O; Tran MA; Montastruc P
Fundam Clin Pharmacol; 1989; 3(6):665-70. PubMed ID: 2575570
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of dopamine autoreceptors elicits "premature ejaculation" in rats.
Napoli-Farris L; Fratta W; Gessa GL
Pharmacol Biochem Behav; 1984 Jan; 20(1):69-72. PubMed ID: 6695002
[TBL] [Abstract][Full Text] [Related]
14. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
Hu XT; Wachtel SR; Galloway MP; White FJ
J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
[TBL] [Abstract][Full Text] [Related]
15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
16. Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors.
Kropf W; Kuschinsky K
Neuropharmacology; 1991 Sep; 30(9):953-60. PubMed ID: 1681452
[TBL] [Abstract][Full Text] [Related]
17. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
18. In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine.
Kujacic M; Carlsson A
Eur J Pharmacol; 1995 May; 278(1):9-15. PubMed ID: 7664818
[TBL] [Abstract][Full Text] [Related]
19. The ergolene derivative MPME induces in the rat a behavioural syndrome associated with activation of dopamine D-1 receptors belonging to the dotted type of forebrain dopamine nerve terminals.
Ogren SO; Fuxe K; Angeby K; Köhler C
Eur J Pharmacol; 1984 Oct; 106(1):79-89. PubMed ID: 6152214
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
